Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
Xiao‐Liang Xing, Zhi-Yong Yao, Jialan Ou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
Xiangjun Shu, Zaiqi Zhang, Zhi-Yong Yao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 22
The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma
Jacek Rysz, Tomasz Konecki, Beata Franczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 643-643
Open Access | Times Cited: 18
Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
Lincheng Ju, Yaxing Shi, Gang Liu
PeerJ (2022) Vol. 10, pp. e14506-e14506
Open Access | Times Cited: 14
Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy
Xuan Zhou, Liangyu Yao, Xiang Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Epigenome-wide methylation study identified two novel CpGs associated with T2DM risk and a network of co-methylated CpGs capable of patient’s classifications
Anil K Giri, Gauri Prasad, Vaisak Parekatt, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 16, pp. 2576-2586
Closed Access | Times Cited: 6
Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs
Chao Hao, Rumeng Li, Zeguang Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
Jie Liu, Jiangfan Xu, Tong Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Comprehensive analysis of basement membrane and immune checkpoint related lncRNA and its prognostic value in hepatocellular carcinoma via machine learning
Ze Jin, Yajun Meng, Mengmeng Wang, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20462-e20462
Open Access | Times Cited: 4
Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma
Yash Jani, Caroline S. Jansen, Margo B. Gerke, et al.
Immunotherapy (2024) Vol. 16, Iss. 6, pp. 405-426
Closed Access | Times Cited: 1
Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma
Yuke Zhang, Jiangwen Dai, Wei-Feng Huang, et al.
Aging (2021) Vol. 13, Iss. 24, pp. 25980-26002
Open Access | Times Cited: 8
An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma
Cheng Tang, Genyi Qu, Yong Xu, et al.
Aging (2021) Vol. 13, Iss. 24, pp. 26046-26062
Open Access | Times Cited: 7
Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
Sheng Xue, Hanxu Guo, Shibo Wei, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 9, pp. 1304-1317
Open Access | Times Cited: 3
Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
Yisheng Yin, Yiqun Tian, Xiang Ren, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-35
Open Access | Times Cited: 3
Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
Jian Li, Wenhua Li, Huaizhi Wang, et al.
Molecular Medicine Reports (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 1
Transcriptome profiling of skeletal muscles from Korean patients with Bethlem myopathy
Seung‐Ah Lee, Ji‐Man Hong, Jung Hwan Lee, et al.
Medicine (2023) Vol. 102, Iss. 9, pp. e33122-e33122
Open Access | Times Cited: 1
Identification of AP002498.1 and LINC01871 as prognostic biomarkers and therapeutic targets for distant metastasis of colorectal adenocarcinoma
Na Wu, Jingyi Chen, Ting-Ru Lin, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients
Hao Li, Lü Chen, Zhi‐Bin Ke, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 6325-6342
Open Access | Times Cited: 1
Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network
Zhiliang Xiao, Menglei Zhang, Zhenduo Shi, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-19
Open Access
Editorial: Long-non coding RNAs in renal cell carcinoma
Zongping Wang, Song Wang, An Zhao
Frontiers in Oncology (2022) Vol. 12
Open Access
Network analysis after epigenome wide methylation study revealed JUP as a regulator of co-methylated risk-module for T2DM
Anil K Giri, Gauri Prasad, Vaisak Parekkat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top